Trilogy International Partners (TSE:TRL) had its price objective reduced by TD Securities from C$4.75 to C$3.00 in a report issued on Friday. They currently have a hold rating on the specialty pharmaceutical company’s stock.
Shares of TRL stock traded down C$0.39 during mid-day trading on Friday, reaching C$1.94. 139,500 shares of the company’s stock traded hands, compared to its average volume of 30,176. Trilogy International Partners has a 12 month low of C$1.77 and a 12 month high of C$6.33.
About Trilogy International Partners
Featured Article: What is the Ex-Dividend Date in Investing?
Receive News & Ratings for Trilogy International Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trilogy International Partners and related companies with MarketBeat.com's FREE daily email newsletter.